Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean S Park

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 24, 2021
Hypofractionated Irradiation and Immune Modulation Therapies: Let's Work Together!Sean S Park, Marjan Boerma
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Sternum First, Perhaps Pelvis LaterBrian J Davis, Sean S Park
Bone|December 14, 2018
Potential role of senescence in radiation-induced damage of the aged skeletonAbhishek Chandra, Sean S Park, Robert J Pignolo
Aging|April 15, 2015
Synergy of cancer immunotherapy and radiotherapyAaron S Mansfield, Sean S Park, Haidong Dong
Case Reports in Oncology|April 24, 2018
Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the LiteratureAdarsh Ravishankar, Sean S Park, Kenneth R Olivier, et al.
Immunotherapy|October 28, 2016
BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanomaRoxana S Dronca, Aaron S Mansfield, Sean S Park, et al.
Frontiers in Immunology|February 19, 2021
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor TherapyWhitney Barham, Ruifeng Guo, Sean S Park, et al.
Advances in Radiation Oncology|April 4, 2022
Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint BlockadeTara Davidson, Henan Zhang, Haidong Dong, et al.
Plos One|June 3, 2014
Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility studyBenjamin Mou, Chris J Beltran, Sean S Park, et al.
International Journal of Particle Therapy|November 28, 2019
Free Breathing versus Breath-Hold Scanning Beam Proton Therapy and Cardiac Sparing in Breast CancerJen Yu, Sean S Park, Michael G Herman, et al.
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|September 24, 2021
Hypofractionated Irradiation and Immune Modulation Therapies: Let's Work Together!Sean S Park, Marjan Boerma
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Sternum First, Perhaps Pelvis LaterBrian J Davis, Sean S Park
Bone|December 14, 2018
Potential role of senescence in radiation-induced damage of the aged skeletonAbhishek Chandra, Sean S Park, Robert J Pignolo
Aging|April 15, 2015
Synergy of cancer immunotherapy and radiotherapyAaron S Mansfield, Sean S Park, Haidong Dong
Case Reports in Oncology|April 24, 2018
Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the LiteratureAdarsh Ravishankar, Sean S Park, Kenneth R Olivier, et al.
Immunotherapy|October 28, 2016
BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanomaRoxana S Dronca, Aaron S Mansfield, Sean S Park, et al.
Frontiers in Immunology|February 19, 2021
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor TherapyWhitney Barham, Ruifeng Guo, Sean S Park, et al.
Advances in Radiation Oncology|April 4, 2022
Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint BlockadeTara Davidson, Henan Zhang, Haidong Dong, et al.
Plos One|June 3, 2014
Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility studyBenjamin Mou, Chris J Beltran, Sean S Park, et al.
International Journal of Particle Therapy|November 28, 2019
Free Breathing versus Breath-Hold Scanning Beam Proton Therapy and Cardiac Sparing in Breast CancerJen Yu, Sean S Park, Michael G Herman, et al.
Pageof 14